Literature DB >> 36001282

Surgical approach to advanced Siewert II cancer: beyond the borders? The West Side.

Arnulf H Hölscher1, Elfriede Bollschweiler2, Ulrich K Fetzner3, Benjamin Babic4.   

Abstract

The surgical approach to Siewert type II cancer should be individualized as there is no "one size fits all" option. Criteria for individualization are epidemiological, functional, oncologic and surgical items. However, our preferred procedure for advanced adenocarcinoma of the esophagogastric junction type II is esophagectomy, if this or transhiatal extended gastrectomy are both possible with R0 resection. Esophagectomy has the advantages of a longer esophageal safety margin, complete mediastinal lymphadenectomy, easier anastomosis, routine minimal invasive gastrolysis with abdominal lymphadenectomy and preservation of a gastric reservoir.
© 2022. Italian Society of Surgery (SIC).

Entities:  

Keywords:  Adenocarcinoma of the esophagogastric junction; Cardia cancer; Ivor Lewis esophagectomy; Nishi classification; Siewert type II adenocarcinoma; Transhiatal extended gastrectomy

Year:  2022        PMID： 36001282     DOI： 10.1007/s13304-022-01363-w

Source DB:  PubMed          Journal:  Updates Surg        ISSN： 2038-131X


  10 in total

1.  Left thoracoabdominal approach versus abdominal-transhiatal approach for gastric cancer of the cardia or subcardia: a randomised controlled trial.

Authors:  Mitsuru Sasako; Takeshi Sano; Seiichiro Yamamoto; Motonori Sairenji; Kuniyoshi Arai; Taira Kinoshita; Atsushi Nashimoto; Masahiro Hiratsuka
Journal:  Lancet Oncol       Date:  2006-08       Impact factor: 41.316

2.  Comment on "Organ Preservation in cT2N0 Rectal Cancer After Neoadjuvant Chemoradiation Therapy".

Authors:  Yoshiaki Kanemoto; Tomohiro Kurokawa; Tetsuya Tanimoto
Journal:  Ann Surg       Date:  2019-12       Impact factor: 12.969

3.  Long-term quality of life after surgery for adenocarcinoma of the esophagogastric junction: extended gastrectomy or transthoracic esophagectomy?

Authors:  Hans Fuchs; Arnulf H Hölscher; Jessica Leers; Marc Bludau; Sebastian Brinkmann; Wolfgang Schröder; Hakan Alakus; Stefan Mönig; Christian A Gutschow
Journal:  Gastric Cancer       Date:  2015-01-28       Impact factor: 7.370

4.  Results of a nation-wide retrospective study of lymphadenectomy for esophagogastric junction carcinoma.

Authors:  Hiroharu Yamashita; Yasuyuki Seto; Takeshi Sano; Hiroyasu Makuuchi; Nobutoshi Ando; Mitsuru Sasako
Journal:  Gastric Cancer       Date:  2016-10-28       Impact factor: 7.370

5.  Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial.

Authors:  Salah-Eddin Al-Batran; Nils Homann; Claudia Pauligk; Thorsten O Goetze; Johannes Meiler; Stefan Kasper; Hans-Georg Kopp; Frank Mayer; Georg Martin Haag; Kim Luley; Udo Lindig; Wolff Schmiegel; Michael Pohl; Jan Stoehlmacher; Gunnar Folprecht; Stephan Probst; Nicole Prasnikar; Wolfgang Fischbach; Rolf Mahlberg; Jörg Trojan; Michael Koenigsmann; Uwe M Martens; Peter Thuss-Patience; Matthias Egger; Andreas Block; Volker Heinemann; Gerald Illerhaus; Markus Moehler; Michael Schenk; Frank Kullmann; Dirk M Behringer; Michael Heike; Daniel Pink; Christian Teschendorf; Carmen Löhr; Helga Bernhard; Gunter Schuch; Volker Rethwisch; Ludwig Fischer von Weikersthal; Jörg T Hartmann; Michael Kneba; Severin Daum; Karsten Schulmann; Jörg Weniger; Sebastian Belle; Timo Gaiser; Fuat S Oduncu; Martina Güntner; Wael Hozaeel; Alexander Reichart; Elke Jäger; Thomas Kraus; Stefan Mönig; Wolf O Bechstein; Martin Schuler; Harald Schmalenberg; Ralf D Hofheinz
Journal:  Lancet       Date:  2019-04-11       Impact factor: 79.321

6.  [Cardia cancer: attempt at a therapeutically relevant classification].

Authors:  J R Siewert; A H Hölscher; K Becker; W Gössner
Journal:  Chirurg       Date:  1987-01       Impact factor: 0.955

7.  Proximal margin length with transhiatal gastrectomy for Siewert type II and III adenocarcinomas of the oesophagogastric junction.

Authors:  S Mine; T Sano; N Hiki; K Yamada; T Kosuga; S Nunobe; T Yamaguchi
Journal:  Br J Surg       Date:  2013-07       Impact factor: 6.939

8.  Effect of Neoadjuvant Chemotherapy Followed by Surgical Resection on Survival in Patients With Limited Metastatic Gastric or Gastroesophageal Junction Cancer: The AIO-FLOT3 Trial.

Authors:  Salah-Eddin Al-Batran; Nils Homann; Claudia Pauligk; Gerald Illerhaus; Uwe M Martens; Jan Stoehlmacher; Harald Schmalenberg; Kim B Luley; Nicole Prasnikar; Matthias Egger; Stephan Probst; Helmut Messmann; Markus Moehler; Wolfgang Fischbach; Jörg T Hartmann; Frank Mayer; Heinz-Gert Höffkes; Michael Koenigsmann; Dirk Arnold; Thomas W Kraus; Kersten Grimm; Stefan Berkhoff; Stefan Post; Elke Jäger; Wolf Bechstein; Ulrich Ronellenfitsch; Stefan Mönig; Ralf D Hofheinz
Journal:  JAMA Oncol       Date:  2017-09-01       Impact factor: 31.777

9.  Techniques and short-term outcomes for total minimally invasive Ivor Lewis esophageal resection in distal esophageal and gastroesophageal junction cancers: pooled data from six European centers.

Authors:  Jennifer Straatman; Nicole van der Wielen; Grard A P Nieuwenhuijzen; Camiel Rosman; Josep Roig; Joris J G Scheepers; Miguel A Cuesta; Misha D P Luyer; Mark I van Berge Henegouwen; Frans van Workum; Suzanne S Gisbertz; Donald L van der Peet
Journal:  Surg Endosc       Date:  2016-04-29       Impact factor: 4.584

10.  Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type II adenocarcinoma: A retrospective single-institution study.

Authors:  Kazuo Koyanagi; Fumihiko Kato; Jun Kanamori; Hiroyuki Daiko; Soji Ozawa; Yuji Tachimori
Journal:  Ann Gastroenterol Surg       Date:  2018-04-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.